Janus Capital Group logo

Janus Capital Group

North America, Colorado, United States, Denver

Description

Janus provides growth and risk-managed investment strategies and manages equity, fixed income, money market, and balanced mutual funds.

Investor Profile

Janus Capital Group has made 18 investments, with 0 in the past 12 months and 17% as lead.

Stage Focus

  • Series D (22%)
  • Series C (22%)
  • Series B (11%)
  • Series F (11%)
  • Series Unknown (11%)
  • Series E (11%)
  • Series A (6%)
  • Corporate Round (6%)

Country Focus

  • United States (89%)
  • Canada (6%)
  • United Kingdom (6%)

Industry Focus

  • Biotechnology
  • Health Care
  • Therapeutics
  • Medical
  • Software
  • Biopharma
  • Genetics
  • Enterprise Software
  • Life Science
  • Medical Device
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Janus Capital Group frequently co-invest with?

OrbiMed
North America, New York, United States, New York
Co-Investments: 4
CA
North America, Massachusetts, United States, Boston
Co-Investments: 3
RTW Investments
North America, New York, United States, New York
Co-Investments: 3
T. Rowe Price
North America, Maryland, United States, Baltimore
Co-Investments: 4
RA Capital Management
North America, Massachusetts, United States, Boston
Co-Investments: 4
Frazier Healthcare Partners
North America, Washington, United States, Seattle
Co-Investments: 2
Foresite Capital
North America, California, United States, San Francisco
Co-Investments: 5
Vivo Capital
North America, California, United States, Palo Alto
Co-Investments: 2
Venrock
North America, California, United States, Palo Alto
Co-Investments: 3
Fidelity
North America, Massachusetts, United States, Boston
Co-Investments: 2

What are some of recent deals done by Janus Capital Group?

Highview Power

London, England, United Kingdom

Highview Power is a renewable energy company that develops liquid-air energy storage solutions for grid applications.

Clean EnergyEnergyEnergy StorageRenewable Energy
Corporate RoundFeb 8, 2021
Bigfoot Biomedical

Milpitas, California, United States

Bigfoot Biomedical is a medical device company changing diabetes care for people with insulin-requiring diabetes.

Artificial Intelligence (AI)Big DataDiabetesHealth CareMedical DevicemHealthPredictive Analytics
Series BMar 21, 2018
Amount Raised: $18,000,000
Silk Road Medical

Sunnyvale, California, United States

Silk Road Medical specializes in providing medical devices and solutions for the treatment of vascular diseases.

Health CareMedicalMedical DeviceTherapeutics
Series CJul 18, 2017
Amount Raised: $47,000,000
Solid Biosciences

Marlborough, Massachusetts, United States

Solid Biosciences is a life science company that conducts research for the treatment of Duchenne muscular dystrophy.

BiotechnologyGeneticsHealth CareMedical
Series CMar 30, 2017
Amount Raised: $50,000,000
Lyft

San Francisco, California, United States

Lyft designs, markets, and operates a mobile application that matches drivers with passengers who request rides.

AppsMobile AppsRide SharingSoftwareTransportation
Series FDec 28, 2015
Amount Raised: $1,000,000,000
AveXis

Dallas, Texas, United States

AveXis is a Biotech company is focused on developing gene therapy for patients with rare and life-threatening neurological genetic diseases.

BiotechnologyGeneticsHealth CareMedical
Series DSep 8, 2015
Amount Raised: $65,000,000
Intellia Therapeutics

Cambridge, Massachusetts, United States

Intellia Therapeutics is a genome editing company that develops curative gene-editing treatments.

BiotechnologyGeneticsHealth CareMedicalTherapeutics
Series BSep 1, 2015
Amount Raised: $70,000,000
Clementia Pharmaceuticals

Montréal, Quebec, Canada

Clementia is a clinical-stage company innovating treatments for people with ultra-rare bone disorders.

BiopharmaBiotechnologyMedical
Series UnknownJun 23, 2015
Amount Raised: $60,000,000
REGENXBIO

Rockville, Maryland, United States

REGENXBIO develops adeno-associated viral vector-based therapeutics and research tools, offering NAV, a recombinant AAV-vector.

BiopharmaBiotechnologyGeneticsTherapeutics
Series DMay 20, 2015
Amount Raised: $70,500,000
Edge Therapeutics

Berkeley Heights, New Jersey, United States

Edge Therapeutics, a biotechnology company, transforms FDA-approved drugs into therapies that address unmet acute neurological conditions.

BiotechnologyHealth CareMedical
Series CApr 9, 2015
Amount Raised: $56,000,000